Onkologie. 2025:19(5):316-319 | DOI: 10.36290/xon.2025.057

Desmoplastic melanoma of the skin arising on the scalp: a case report

Vladimír Bartoš1, Michal Urda2
1 Martinské bioptické centrum, s. r. o., Martin
2 Oddelenie pneumológie a ftizeológie, Fakultná nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica

Desmoplastic melanoma (DM) is a rare type of cutaneous melanoma characterized by specific clinical, biological, and histomorphological features. Grossly, it rather looks like a benign skin lesion and therefore it is usually diagnosed late at a locally advanced stage. Herein, a case of a 73-year-old woman with cutaneous DM arising on the scalp is described. It histologically consisted of atypical spindle and pleomorphic tumor cell population, which was dispersely distributed within desmoplastic stroma and "masked" by massive lymphocytic cellulisation. The tumor invaded deeply into the subcutaneous tissue and was in close proximity to the resection margins. A wide reexcision of the affected site was done with subsequently confirmed melanoma residues. PET/CT examination did not reveal regional or distant metastases. Biopsy diagnosis of DM is not easy and brings many difficulties for the pathologist. It may also be a challenge for the clinician, especially in terms of choosing the optimal treatment strategy. The positive news is that compared to "common" melanomas, it appears to have a more favorable prognosis and responds well to immunotherapy.

Keywords: desmoplastic melanoma, S100, SOX10, BRAF, prognosis.

Accepted: November 25, 2025; Published: December 15, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartoš V, Urda M. Desmoplastic melanoma of the skin arising on the scalp: a case report. Onkologie. 2025;19(5):316-319. doi: 10.36290/xon.2025.057.
Download citation

References

  1. Boada Garcia A, Quer Pi-Sunyer A, Richarz N, et al. Uptade on the diagnosis and management of desmoplastic melanoma. Actas Dermosifiliogr. 2022;113(1):47-57. Go to original source... Go to PubMed...
  2. Hughes TM, Williams GJ, Gyorki DE, et al. Desmoplastic melanoma: a review of its pathology and clinical behaviour, and of management recommendations in published guidelines. J Eur Acad Dermatol Venereol. 2021;35(6):1290-1298. Go to original source... Go to PubMed...
  3. Kendra KL, Contreras CM, Verschraegen CF, et al. Management of cutaneous melanoma, with a special focus on desmoplastic melanoma. Am Soc Clin Oncol Educ Book. 2025;45(3):e472752. Go to original source... Go to PubMed...
  4. Chen LL, Jaimes N, Barker CA, et al. Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68(5):825-833. Go to original source... Go to PubMed...
  5. Busam KJ, Mujumdar U, Hummer AJ, et al. Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol. 2004;28(11):1518-1525. Go to original source... Go to PubMed...
  6. Wasif N, Gray JR, Pockaj BA. Desmoplastic melanoma - the step-child in the melanoma family? J Surg Oncol. 2011;103(2):158-162. Go to original source... Go to PubMed...
  7. Laeijendecker AE, El Sharouni MA, Sigurdsson V, et al. Des­moplastic melanoma: The role of pure and mixed subtype in sentinel lymph node biopsy and survival. Cancer Medicine. 2020;9(2):671-677. Go to original source... Go to PubMed...
  8. Chu S, Schrom KP, Tripathi R, et al. Pure and mixed desmoplastic melanoma: A retrospective clinicopathologic comparision of 33 cases. Am J Dermatopathol. 2021;43(11):776-780. Go to original source... Go to PubMed...
  9. Miller DD, Emley A, Yang S, et al. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal. Modern Pathology. 2012;25(4):505-515. Go to original source... Go to PubMed...
  10. Conic RZ, Ko J, Allam SH, et al. Mixed versus pure variants of desmoplastic melanoma: The Cleveland Clinic experience. Ann Plast Surg. 2018;80(3):277-281. Go to original source... Go to PubMed...
  11. Kottschade LA, Grotz TE, Dronca RS, et al. Rare presentations of primary melanoma and special populations: a systemic review. Am J Clin Oncol. 2014;37(6):635-641. Go to original source... Go to PubMed...
  12. Feng Z, Wu X, Chen V, et al. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007. J Cutan Pathol. 2011;38(8):616-624. Go to original source... Go to PubMed...
  13. Vongtama R, Safa A, Gallardo D, et al. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma. Head Neck. 2003;25(6):423-428. Go to original source... Go to PubMed...
  14. Smith VA, Lentsch EJ. Sentinel node biopsy in head and neck desmoplastic melanoma: An analysis of 244 cases. Laryngoscope. 2012;122(1):116-120. Go to original source... Go to PubMed...
  15. Pawlik TM, Ross MI, Prieto VG, et al. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer. 2006;106(4):900-906. Go to original source... Go to PubMed...
  16. Eroglu Z, Zaretsky JM, Hu-Lieskovan S, et al. High response rate to PD-1 blockade in desmoplastic melanomas. Nature. 2018;553(7688):347-350. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.